All members in the study had at least six months without any diabetes-related claims preceding the first diabetes-related claim, and 24 months of continuous coverage after the first diabetes-related claim
When it comes to sleep, peptides present a fascinating therapeutic prospect
March ushered in the first wave of off-patent competition for semaglutide, the active ingredient in Ozempic and Wegovy, marking a global turning point in metabolic medicine
Ever heard of glutathione injections
Chronic low-grade inflammation, as seen in diabetes, hypertension, and metabolic syndrome, initiates and perpetuates ED, ultimately leading to plaque destabilization and thrombosis
While the drugs have recently surged in popularity, Rothman emphasized they arent new